<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
60422-250-01
</NDCCode>
<PackageDescription>
1 VIAL, SINGLE-USE in 1 BOX (60422-250-01) / 10 mL in 1 VIAL, SINGLE-USE
</PackageDescription>
<NDC11Code>
60422-0250-01
</NDC11Code>
<ProductNDC>
60422-250
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Tocilizumab
</NonProprietaryName>
<DosageFormName>
INJECTION, SOLUTION, CONCENTRATE
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20100108
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Chugai Pharmaceutical Co., Ltd.
</LabelerName>
<SubstanceName>
TOCILIZUMAB
</SubstanceName>
<StrengthNumber>
200
</StrengthNumber>
<StrengthUnit>
mg/10mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Unfinished
</Status>
<LastUpdate>
2026-02-24
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20271231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
08-JAN-10
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>